Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs
NCT03820102 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-02-05
Summary
1. Study Changes in lipid profile and the impact of Insulin resistance on virological response in patients with Hepatitis C viral infection treated by Direct Acting Antiviral agents
2. The assessment of serum vitamin D levels in HCV infected patients and predictive value of pre-treatment serum vitamin D level for achieving sustained virological response at 12 weeks post-treatment
Conditions
- HCV
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Laila Abd Elbaky, profesor · Assiut University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-31
- Primary Completion
- 2019-09-30
- Completion
- 2019-10-31
More Related Trials
-
Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV
NCT03356405 ·Status: COMPLETED
-
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
NCT03894696 ·Status: UNKNOWN
-
Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong
NCT03993925 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients
NCT01413360 ·Status: COMPLETED ·Phase: PHASE4
-
Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals Therapy
NCT06872047 ·Status: NOT_YET_RECRUITING
-
Risk of HCC in Cirrhotic Patients Post DAAs Ttt
NCT03414554 ·Status: UNKNOWN
-
Hepatitis C Self-Management
NCT00328042 ·Status: COMPLETED ·Phase: NA
-
Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
NCT00948220 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024 ·Status: COMPLETED
-
Testing and Treating Hepatitis C in Community Pharmacies
NCT02706223 ·Status: COMPLETED ·Phase: NA
-
Effect of Hepatitis C Clearance on Insulin Resistance
NCT04457050 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolic Changes in Chronic HCV Patients Receiving DAAS
NCT04211844 ·Status: UNKNOWN
-
Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute Therapy
NCT03483818 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hepatitis c by Using Direct-acting Antiviral
NCT05372874 ·Status: UNKNOWN
-
Effect of Strategies for the Treatment of Chronic Hepatitis C in Colombia
NCT03895294 ·Status: UNKNOWN ·Phase: NA
-
Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
NCT01159613 ·Status: COMPLETED
-
HCV Treatment Initiation During Acute Psychiatric Admission
NCT04625322 ·Status: UNKNOWN ·Phase: PHASE4
-
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
NCT01474811 ·Status: COMPLETED
-
Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy
NCT01434212 ·Status: UNKNOWN
-
Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
NCT00819026 ·Status: COMPLETED
-
Study on the Prevalence of Hepatitis C In a psychiatRic Population
NCT04600479 ·Status: COMPLETED ·Phase: NA
-
Reaching mEthadone Users Attending Community pHarmacies With HCV
NCT03935906 ·Status: COMPLETED ·Phase: NA
-
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
NCT01448915 ·Status: COMPLETED
-
Chronic Hepatitis C and Insulin Resistance
NCT00707603 ·Status: COMPLETED
-
Pharmacist-led Hepatitis C Management
NCT04322981 ·Status: UNKNOWN ·Phase: PHASE4